Press Inquiry Form
If you are a journalist, editor, or media representative interested in covering AIMA and our innovations, please fill out the form below. We will get back to you as soon as possible.
Inflammatory Markers in Blood Tests: An Overview for Medical Professionals
Inflammation is a key biological response to pathological conditions such as infections, trauma, autoimmune diseases, and cancer. To diagnose and monitor inflammatory processes, laboratory blood tests are widely used to identify both specific and non-specific biomarkers. Based on data from authoritative sources—including the National Institutes of Health (NIH), World Health Organization (WHO), The Lancet, and Journal of Clinical Pathology—this article provides a comprehensive overview of the main inflammatory biomarkers, their clinical relevance, and limitations.
Key Inflammatory Biomarkers in Blood
C-Reactive Protein (CRP)
CRP is a highly sensitive acute-phase marker synthesized by hepatocytes in response to interleukin-6 (IL-6).
Reference range: <10 mg/L (standard); <3 mg/L for high-sensitivity CRP (hs-CRP).
Clinical relevance: Elevated CRP levels are typical in bacterial infections, sepsis, autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), and acute cardiovascular events. hs-CRP is also used to stratify atherosclerosis and myocardial infarction risk.
Limitations: Non-specific; may increase with obesity, smoking, or physical stress.
Sources: Circulation, 2023; NIH, 2024.
Erythrocyte Sedimentation Rate (ESR)
ESR reflects red blood cell aggregation under the influence of acute-phase proteins such as fibrinogen and immunoglobulins.
Reference range:
Men: 0–15 mm/hr
Women: 0–20 mm/hr (age adjustments apply)
Clinical relevance: Elevated ESR is observed in infections, cancers (e.g., multiple myeloma), autoimmune disorders, and chronic inflammation.
Limitations: Low specificity; results affected by anemia, hypergammaglobulinemia, and age.
Source: Mayo Clinic Proceedings, 2024.
Leukocyte Count and Differential
Complete blood count (CBC) with differential evaluates total leukocyte levels and subtypes.
Reference range: 4.5–11.0 × 10⁹/L.
Clinical relevance:
• Leukocytosis: Bacterial infections, stress, leukemia. Neutrophilia often indicates acute bacterial infection, while lymphocytosis is common in viral or lymphoproliferative diseases.
• Leukopenia: Suggests viral infections (e.g., HIV, hepatitis), aplastic anemia, or bone marrow suppression.
• Left shift: Presence of immature neutrophils (band cells) indicates severe infection or sepsis.
Limitations: Requires differential analysis for proper interpretation.
Sources: Blood, 2023; Cleveland Clinic Journal of Medicine, 2024.
Fibrinogen
Fibrinogen is a coagulation factor that increases during inflammation.
Reference range: 2–4 g/L.
Clinical relevance: Elevated in acute infections, myocardial infarction, stroke, and chronic inflammatory conditions. Also a predictor of thrombotic risk.
Limitations: May be elevated during pregnancy or with dysfibrinogenemia.
Source: Journal of Thrombosis and Haemostasis, 2023.
Ferritin
Ferritin reflects iron storage and is also an acute-phase reactant.
Reference range:
Men: 20–250 µg/L
Women: 10–120 µg/L
Clinical relevance: Elevated ferritin levels are associated with chronic inflammation, hemochromatosis, malignancies (e.g., lymphomas), and macrophage activation syndrome.
Limitations: Requires contextual interpretation alongside serum transferrin and iron levels.
Source: American Journal of Hematology, 2024.
Procalcitonin (PCT)
PCT is a highly specific marker of bacterial infections.
Reference range: <0.5 ng/mL
Clinical relevance: Elevated in sepsis, pneumonia, and other severe bacterial infections. Useful in distinguishing bacterial from viral infections and in antibiotic therapy monitoring.
Limitations: False positives may occur in renal failure or severe trauma.
Source: The Lancet Infectious Diseases, 2024.
Cytokines (IL-6, TNF-α)
IL-6 and TNF-α are key pro-inflammatory cytokines elevated during systemic inflammation.
Clinical relevance: IL-6 is elevated in cytokine storm, sepsis, rheumatoid arthritis, and post-COVID syndromes. These markers are mainly used in research and specialized settings.
Limitations: Expensive and not part of routine diagnostics.
Source: Nature Reviews Immunology, 2024.
Serum Amyloid A (SAA)
SAA is a less-known but sensitive acute-phase protein.
Clinical relevance: Elevated in infections, autoimmune diseases, and amyloidosis.
Limitations: Limited availability in routine practice.
Source: Journal of Clinical Investigation, 2023.
Clinical Application and Interpretation
Use cases:
• Diagnosis of infectious and non-infectious inflammatory conditions
• Monitoring treatment efficacy (e.g., CRP and PCT decline during effective antibiotic therapy)
• Risk stratification (e.g., hs-CRP for cardiovascular risk)
• Differential diagnosis (e.g., PCT to distinguish bacterial vs viral infections)
Interpretation algorithm:
1. Assess clinical symptoms (fever, pain, fatigue)
2. Combine multiple markers (e.g., CRP + ESR + CBC)
3. Consider influencing factors (age, comorbidities, medications)
4. Order further diagnostics if necessary (cultures, imaging)
Limitations and Recommendations
• Non-specificity: Most markers (e.g., CRP, ESR) do not indicate the exact cause of inflammation
• False results: For instance, ESR may be normal in acute inflammation in elderly patients
• Dynamic monitoring is more informative than isolated measurements
• Individualized interpretation in clinical context is essential
Specialist recommendations:
• Use a panel of markers (CRP, ESR, PCT, CBC) for improved accuracy
• Apply hs-CRP for cardiovascular risk assessment
• Use PCT in critical care for differentiating bacterial from viral infections
Conclusion
Blood-based inflammatory biomarkers such as CRP, ESR, leukocyte counts, fibrinogen, ferritin, PCT, and cytokines are central to inflammation diagnostics and monitoring. Their interpretation requires a multifactorial approach, integrating clinical context and dynamic data. Emerging evidence highlights the growing role of combining conventional and novel biomarkers (e.g., SAA, IL-6) to improve diagnostic precision.
Sources:
• National Institutes of Health (NIH), 2024
• Circulation, 2023
• Mayo Clinic Proceedings, 2024
• Blood, 2023
• Cleveland Clinic Journal of Medicine, 2024
• Journal of Thrombosis and Haemostasis, 2023
• American Journal of Hematology, 2024
• The Lancet Infectious Diseases, 2024
• Nature Reviews Immunology, 2024
• Journal of Clinical Investigation, 2023
Note: All data verified as of April 2025 based on current publications and official medical guidelines.
Key Inflammatory Biomarkers in Blood
C-Reactive Protein (CRP)
CRP is a highly sensitive acute-phase marker synthesized by hepatocytes in response to interleukin-6 (IL-6).
Reference range: <10 mg/L (standard); <3 mg/L for high-sensitivity CRP (hs-CRP).
Clinical relevance: Elevated CRP levels are typical in bacterial infections, sepsis, autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), and acute cardiovascular events. hs-CRP is also used to stratify atherosclerosis and myocardial infarction risk.
Limitations: Non-specific; may increase with obesity, smoking, or physical stress.
Sources: Circulation, 2023; NIH, 2024.
Erythrocyte Sedimentation Rate (ESR)
ESR reflects red blood cell aggregation under the influence of acute-phase proteins such as fibrinogen and immunoglobulins.
Reference range:
Men: 0–15 mm/hr
Women: 0–20 mm/hr (age adjustments apply)
Clinical relevance: Elevated ESR is observed in infections, cancers (e.g., multiple myeloma), autoimmune disorders, and chronic inflammation.
Limitations: Low specificity; results affected by anemia, hypergammaglobulinemia, and age.
Source: Mayo Clinic Proceedings, 2024.
Leukocyte Count and Differential
Complete blood count (CBC) with differential evaluates total leukocyte levels and subtypes.
Reference range: 4.5–11.0 × 10⁹/L.
Clinical relevance:
• Leukocytosis: Bacterial infections, stress, leukemia. Neutrophilia often indicates acute bacterial infection, while lymphocytosis is common in viral or lymphoproliferative diseases.
• Leukopenia: Suggests viral infections (e.g., HIV, hepatitis), aplastic anemia, or bone marrow suppression.
• Left shift: Presence of immature neutrophils (band cells) indicates severe infection or sepsis.
Limitations: Requires differential analysis for proper interpretation.
Sources: Blood, 2023; Cleveland Clinic Journal of Medicine, 2024.
Fibrinogen
Fibrinogen is a coagulation factor that increases during inflammation.
Reference range: 2–4 g/L.
Clinical relevance: Elevated in acute infections, myocardial infarction, stroke, and chronic inflammatory conditions. Also a predictor of thrombotic risk.
Limitations: May be elevated during pregnancy or with dysfibrinogenemia.
Source: Journal of Thrombosis and Haemostasis, 2023.
Ferritin
Ferritin reflects iron storage and is also an acute-phase reactant.
Reference range:
Men: 20–250 µg/L
Women: 10–120 µg/L
Clinical relevance: Elevated ferritin levels are associated with chronic inflammation, hemochromatosis, malignancies (e.g., lymphomas), and macrophage activation syndrome.
Limitations: Requires contextual interpretation alongside serum transferrin and iron levels.
Source: American Journal of Hematology, 2024.
Procalcitonin (PCT)
PCT is a highly specific marker of bacterial infections.
Reference range: <0.5 ng/mL
Clinical relevance: Elevated in sepsis, pneumonia, and other severe bacterial infections. Useful in distinguishing bacterial from viral infections and in antibiotic therapy monitoring.
Limitations: False positives may occur in renal failure or severe trauma.
Source: The Lancet Infectious Diseases, 2024.
Cytokines (IL-6, TNF-α)
IL-6 and TNF-α are key pro-inflammatory cytokines elevated during systemic inflammation.
Clinical relevance: IL-6 is elevated in cytokine storm, sepsis, rheumatoid arthritis, and post-COVID syndromes. These markers are mainly used in research and specialized settings.
Limitations: Expensive and not part of routine diagnostics.
Source: Nature Reviews Immunology, 2024.
Serum Amyloid A (SAA)
SAA is a less-known but sensitive acute-phase protein.
Clinical relevance: Elevated in infections, autoimmune diseases, and amyloidosis.
Limitations: Limited availability in routine practice.
Source: Journal of Clinical Investigation, 2023.
Clinical Application and Interpretation
Use cases:
• Diagnosis of infectious and non-infectious inflammatory conditions
• Monitoring treatment efficacy (e.g., CRP and PCT decline during effective antibiotic therapy)
• Risk stratification (e.g., hs-CRP for cardiovascular risk)
• Differential diagnosis (e.g., PCT to distinguish bacterial vs viral infections)
Interpretation algorithm:
1. Assess clinical symptoms (fever, pain, fatigue)
2. Combine multiple markers (e.g., CRP + ESR + CBC)
3. Consider influencing factors (age, comorbidities, medications)
4. Order further diagnostics if necessary (cultures, imaging)
Limitations and Recommendations
• Non-specificity: Most markers (e.g., CRP, ESR) do not indicate the exact cause of inflammation
• False results: For instance, ESR may be normal in acute inflammation in elderly patients
• Dynamic monitoring is more informative than isolated measurements
• Individualized interpretation in clinical context is essential
Specialist recommendations:
• Use a panel of markers (CRP, ESR, PCT, CBC) for improved accuracy
• Apply hs-CRP for cardiovascular risk assessment
• Use PCT in critical care for differentiating bacterial from viral infections
Conclusion
Blood-based inflammatory biomarkers such as CRP, ESR, leukocyte counts, fibrinogen, ferritin, PCT, and cytokines are central to inflammation diagnostics and monitoring. Their interpretation requires a multifactorial approach, integrating clinical context and dynamic data. Emerging evidence highlights the growing role of combining conventional and novel biomarkers (e.g., SAA, IL-6) to improve diagnostic precision.
Sources:
• National Institutes of Health (NIH), 2024
• Circulation, 2023
• Mayo Clinic Proceedings, 2024
• Blood, 2023
• Cleveland Clinic Journal of Medicine, 2024
• Journal of Thrombosis and Haemostasis, 2023
• American Journal of Hematology, 2024
• The Lancet Infectious Diseases, 2024
• Nature Reviews Immunology, 2024
• Journal of Clinical Investigation, 2023
Note: All data verified as of April 2025 based on current publications and official medical guidelines.